<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="335617">
  <stage>Registered</stage>
  <submitdate>5/07/2010</submitdate>
  <approvaldate>5/07/2010</approvaldate>
  <actrnumber>ACTRN12610000538044</actrnumber>
  <trial_identification>
    <studytitle>Australian study of the effects of strict potassium restriction on nerve function in patients with chronic kidney disease</studytitle>
    <scientifictitle>Australian study of the effects of strict potassium restriction on neuropathy in chronic kidney disease</scientifictitle>
    <utrn>U1111-1115-5119</utrn>
    <trialacronym>AUSSPRINT</trialacronym>
    <secondaryid>none</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Stage 3-4 Chronic kidney disease</healthcondition>
    <healthcondition>Neuropathy</healthcondition>
    <conditioncode>
      <conditioncode1>Neurological</conditioncode1>
      <conditioncode2>Other neurological disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Renal and Urogenital</conditioncode1>
      <conditioncode2>Kidney disease</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Strict dietary potassium (K+) restriction with Dietitian support - including an initial consultation, 2 week follow-up consultation with fortnightly phone calls for the first 3 months after which the patient will receive a phone call one month and a face to face consultation the next for the remaining months of the total 24 month trial.  If serum K+ levels exceed the target of 3.5-4.5mmol/L for more than 2 months dietary advice will be supplemented by an oral solution of resonium (15-30mg per night as prescribed by the treating physician based on the clinical variables) until K+ falls back within normal range.</interventions>
    <comparator>Routine clinical care involving standard monthly review by renal physician with monthly electrolyte levels, treatment with resonium only if K+ levels exceed 6.0mmol/L.</comparator>
    <control>Active</control>
    <interventioncode>Prevention</interventioncode>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>The development of neuropathy assessed by the total neuropathy score (0-28 with a higher score indicating worse neuropathy) and the neuropathy symptom score (0-no neuropathy to 3-disabling neuropathy)</outcome>
      <timepoint>Every 6 months after randomisation for 2 years</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Peripheral nerve excitability parameters (threshold electrotonus, superexcitability)</outcome>
      <timepoint>Every 6 months after randomisation for 2 years</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Sural nerve sensory amplitude (uV) as measured by routine nerve conduction equipment</outcome>
      <timepoint>Every 6 months after randomisation for 2 years</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Health related quality of life using the physical function subscale of SF36</outcome>
      <timepoint>Every 6 months after randomisation for 2 years</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Handgrip strength by dynamometry</outcome>
      <timepoint>Every 6 months after randomisation for 2 years</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Timed 6m walk</outcome>
      <timepoint>Every 6 months after randomisation for 2 years</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>History of Chronic Kidney Disease (stage 3 or 4), as defined by the estimated glomerular filtration rate.

Monthly attendance for clinical care at Kidney Care Centre, Prince of Wales Hospital.

Able to provide informed consent</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>75</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Current or past history of dialysis therapy or previous renal transplantation. 

Cognitively impaired

Unable to speak and/or understand English

Pregnant</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Randomisation will be performed by the National Health and Medical Research Council (NHMRC) Clinical Trials Centre 24-hour Randomisation Service, based at the University of Sydney.</concealment>
    <sequence>Randomisation will be stratified according to the severeity of renal failure (stage 3 or 4) and presence or absence of diabetes.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Factorial</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>10/07/2010</anticipatedstartdate>
    <actualstartdate>26/08/2010</actualstartdate>
    <anticipatedenddate>1/12/2012</anticipatedenddate>
    <actualenddate>23/11/2012</actualenddate>
    <samplesize>80</samplesize>
    <actualsamplesize>47</actualsamplesize>
    <recruitmentstatus>Closed: follow-up complete</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Dr Arun Krishnan</primarysponsorname>
    <primarysponsoraddress>University of New South Wales and Institute of Neurological Sciences, Prince of Wales Hospital, Barker Street, Randwick NSW 2031</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>National Health and Medical Research Council</fundingname>
      <fundingaddress>National Health and Medical Research Council
GPO Box 1421, Canberra ACT 2601</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Prof Matthew Kiernan</sponsorname>
      <sponsoraddress>University of New South Wales and Institute of Neurological Sciences, Prince of Wales Hospital, Barker Street, Randwick NSW 2031</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Prof Bruce Pussell</othercollaboratorname>
      <othercollaboratoraddress>Department of Nephrology
Prince of Wales Hospital
Barker Street, Randwick NSW 2031</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Ms Adrienne Kirby</othercollaboratorname>
      <othercollaboratoraddress>NHMRC Clinical Trials Centre
Locked Bag 77
Camperdown  NSW 1450</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Ms Margaret Holyday</othercollaboratorname>
      <othercollaboratoraddress>Department of Nutrition and Dietetics
Prince of Wales Hospital
Barker Street  Randwick  NSW  2031</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Ms Maria Chan</othercollaboratorname>
      <othercollaboratoraddress>Department of Nutrition and Dietetics
St George Hospital 
Kogarah  NSW 2217</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Dr Cindy Lin</othercollaboratorname>
      <othercollaboratoraddress>University of New South Wales and Institute of Neurological Sciences
Prince of Wales Hospital
Barker Street, Randwick NSW 2031</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Ms Karen Rounsley</othercollaboratorname>
      <othercollaboratoraddress>Department of Nutrition and Dietetics
Prince of Wales Hospital
Barker Street, Randwick  NSW  2031</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Ms Ria Arnold</othercollaboratorname>
      <othercollaboratoraddress>Address: University of New South Wales and Institute of Neurological Sciences
Prince of Wales Hospital,
Barker Street, Randwick NSW 2031</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Dr Tim Pianta</othercollaboratorname>
      <othercollaboratoraddress>Department of Nephrology
Prince of Wales Hospital
Barker Street, Randwick NSW 2031</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>People with kidney failure often develop a condition called uraemic neuropathy, where the function of the nerves in the hands and feet is impaired. These changes cause weakness, numbness and tingling. Our studies have shown that high levels of potassium in the bloodstream may cause uraemic neuropathy.

The purpose of this study is to investigate whether reducing the amount of potassium in a patients diet may help prevent neuropathy.</summary>
    <trialwebsite />
    <publication>Not yet applicable </publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>South Eastern Sydney Illawarra Area Health Service</ethicname>
      <ethicaddress>Room G71, East Wing
Edmund Blackett Building
Prince of Wales Hospital 
High St Randwick NSW 2031</ethicaddress>
      <ethicapprovaldate>10/05/2010</ethicapprovaldate>
      <hrec>1/10/0006</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>A/Prof</title>
      <name>Arun Krishnan</name>
      <address>Room 313 Wallace Wurth Building
University of New South Wales Randwick NSW 2052</address>
      <phone>+61 2 9385 2756</phone>
      <fax>+61 2 9385 3484</fax>
      <email>arun.krishnan.unsw.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Arun Krishnan</name>
      <address>Room 313 Wallace Wurth Building
University of New South Wales Randwick NSW 2052</address>
      <phone>+61 2 9385 2756</phone>
      <fax>+61 2 9385 3484</fax>
      <email>arun.krishnan.unsw.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Ria Arnold</name>
      <address>School of Medical Sciences, 3E Wallace Wurth Building, University of New South Wales, Randwick, NSW 2052</address>
      <phone>+61 2 9382 2413</phone>
      <fax />
      <email>ria.arnold@unsw.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Arun Krishnan</name>
      <address>Translational Neuroscience Facility
Room 313
Wallace Wurth Building, High St, Randwick
School of Medical Sciences
University of New South Wales 2052</address>
      <phone>+61 2 93822413</phone>
      <fax />
      <email>arun.krishnan@unsw.edu.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>